AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Photocure ASA

Remuneration Information Nov 24, 2016

3714_dirs_2016-11-24_56658144-f0bd-4e89-91d5-502975aed14d.html

Remuneration Information

Open in Viewer

Opens in native device viewer

Photocure ASA: Update on management shareholdings and exercise of employee share

Photocure ASA: Update on management shareholdings and exercise of employee share

Update on management shareholdings and exercise of employee share options in

Photocure ASA ("the Company").

Oslo, Norway, 24 November 2016

1.    Participants in the Photocure's share option program have on November

23rd 2016 exercised a total number of 12,481 options. Each option gives the

right to receive one share in the Company. The company has resolved a share

capital increase as a consequence of employees exercising vested options granted

under the company's employee incentive scheme.

2.    Options exercised by primary insiders 23rd of November 2016:

Espen Njåstein, Head Nordic Cancer Commercial Operations, has exercised 5,000

options in the Company, corresponding to 5,000 shares at the strike of NOK

27.39.

3.    New holding

After exercising options, Espen Njåstein holds 80,450 unexercised options in the

Company, corresponding to 13,000 shares at the strike price of NOK

27.39, 23,300 shares at the strike price of NOK 32.78, 16,350 shares at the

strike price of NOK 38.50, and 27,800 shares at the strike price of NOK 40.15.

After completion of the abovementioned transactions, Espen Njåstein holds 5,000

shares in the Company.

Photocure

CFO Erik Dahl

Tel: +47 450 55 000

Email: [email protected]

This information is subject to the disclosure requirements pursuant to section

5-12 of the Norwegian Securities Trading Act.

Talk to a Data Expert

Have a question? We'll get back to you promptly.